JustMelt MedSpa

JustMelt MedSpa operates in Manhattan, New York, under the medical direction of Dr. Michael Greenblatt, offering peptide-based weight management programs alongside aesthetic medicine services. The practice integrates GLP-1 receptor agonist therapies with body contouring and dermatological treatments, providing patients access to both metabolic and cosmetic interventions within a single clinical setting. The clinic serves New York City residents through both in-person appointments at their Manhattan location and telehealth consultations for eligible treatment protocols.

The weight loss program at JustMelt MedSpa centers on two FDA-approved peptide medications: Semaglutide and Tirzepatide. Semaglutide functions as a glucagon-like peptide-1 (GLP-1) receptor agonist that regulates appetite and glucose metabolism through subcutaneous injection, typically administered weekly. Tirzepatide operates through dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor activation, offering an alternative mechanism for patients who require different metabolic pathway targeting. Both medications require medical supervision, baseline laboratory assessment, and ongoing monitoring of weight trends, side effect profiles, and metabolic markers. The clinic structures these programs with initial consultations to establish candidacy, determine appropriate dosing schedules, and coordinate with any existing medical conditions or medications that may influence treatment selection.

Dr. Michael Greenblatt leads the clinical team at JustMelt MedSpa, bringing medical oversight to both the peptide weight management protocols and the aesthetic service offerings. The practice approach combines pharmacological weight loss interventions with complementary body contouring procedures, allowing patients to address both metabolic factors and physical appearance concerns through coordinated treatment planning. Injectable treatments for facial aesthetics, skin tightening modalities, and sexual wellness services expand the clinic's scope beyond weight management alone. This integrated model enables patients to work with a single provider team across multiple health and appearance goals rather than coordinating care between separate practices.

Patients beginning peptide therapy at JustMelt MedSpa undergo an initial evaluation that includes medical history review, current medication assessment, weight loss goal discussion, and determination of contraindications to GLP-1 or GIP receptor agonist use. The clinic provides education on injection technique for self-administration, expected timelines for appetite suppression and weight reduction, common side effects including nausea and gastrointestinal changes, and protocols for dose escalation. Follow-up visits or telehealth check-ins occur at regular intervals to assess tolerance, adjust dosing, monitor for adverse effects, and evaluate progress toward target weight ranges. The practice also discusses maintenance strategies, potential duration of therapy, and considerations for transitioning off medication when appropriate.

The availability of telehealth consultations at JustMelt MedSpa extends access to peptide weight loss programs for New York patients who face scheduling constraints or prefer remote medical visits for ongoing management. Initial assessments may occur via video consultation, with medication shipped to the patient's address following prescription approval. This delivery model suits the self-administered nature of Semaglutide and Tirzepatide injections while maintaining medical supervision through virtual follow-up appointments. For patients combining weight loss peptides with in-office aesthetic procedures such as body contouring or skin tightening, the practice coordinates both remote and in-person visit schedules to optimize treatment sequencing and results monitoring across multiple service lines.